RE: Taken from the Daily Mail7 Jun 2022 08:19
Clinical trials for the drug dostarlimab in treating colorectal cancer have had incredible results, curing all patients of their cancer
One researcher at New York's Memorial Sloan Kettering Cancer Center said that it was the 'first time this has happened' in a cancer trial
Researchers say that the success of this monoclonal antibody drug is especially important for people of younger ages as cancer treatment can harm fertility
It is still too early to declare the drug a cancer cure because the trial was small and limited in scope, researchers note, with only 18 participants
The doctors are now expanding the trial for patients with gastric, prostate, and pancreatic cancers